Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy
ClinicalTrials.gov study NCT01019616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Aerobic and Resistance Exercise Training in Individuals with Cancer Cachexia
ClinicalTrials.gov study NCT06737692. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
ClinicalTrials.gov study NCT07092514. IPD Sharing: YES. Countries: 1. Publications: 0.
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
ClinicalTrials.gov study NCT01402271. IPD Sharing: Not stated. Countries: 3. Publications: 0.
MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT00868595. IPD Sharing: NO. Countries: 1. Publications: 0.
HR+/HER2- Advanced Breast Cancer and Endocrine Resistance
ClinicalTrials.gov study NCT03322215. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
ClinicalTrials.gov study NCT02850302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06014528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
ClinicalTrials.gov study NCT04545710. IPD Sharing: NO. Countries: 1. Publications: 0.
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT00959959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT02964988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT04704505. IPD Sharing: Not stated. Countries: 2. Publications: 0.
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
ClinicalTrials.gov study NCT04249947. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT01155791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
ClinicalTrials.gov study NCT01368003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)
ClinicalTrials.gov study NCT02054793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT02125617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05124795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer
ClinicalTrials.gov study NCT06320392. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
ClinicalTrials.gov study NCT03287271. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.